579 related articles for article (PubMed ID: 19671755)
1. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells.
Colland F; Formstecher E; Jacq X; Reverdy C; Planquette C; Conrath S; Trouplin V; Bianchi J; Aushev VN; Camonis J; Calabrese A; Borg-Capra C; Sippl W; Collura V; Boissy G; Rain JC; Guedat P; Delansorne R; Daviet L
Mol Cancer Ther; 2009 Aug; 8(8):2286-95. PubMed ID: 19671755
[TBL] [Abstract][Full Text] [Related]
2. The multifaceted roles of USP7: new therapeutic opportunities.
Nicholson B; Suresh Kumar KG
Cell Biochem Biophys; 2011 Jun; 60(1-2):61-8. PubMed ID: 21468693
[TBL] [Abstract][Full Text] [Related]
3. USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.
Fan YH; Cheng J; Vasudevan SA; Dou J; Zhang H; Patel RH; Ma IT; Rojas Y; Zhao Y; Yu Y; Zhang H; Shohet JM; Nuchtern JG; Kim ES; Yang J
Cell Death Dis; 2013 Oct; 4(10):e867. PubMed ID: 24136231
[TBL] [Abstract][Full Text] [Related]
4. Targeting HAUSP in both p53 wildtype and p53-mutant tumors.
Tavana O; Sun H; Gu W
Cell Cycle; 2018; 17(7):823-828. PubMed ID: 29616860
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors.
Chen C; Song J; Wang J; Xu C; Chen C; Gu W; Sun H; Wen X
Bioorg Med Chem Lett; 2017 Feb; 27(4):845-849. PubMed ID: 28108249
[TBL] [Abstract][Full Text] [Related]
6. Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10.
Zhang W; Sartori MA; Makhnevych T; Federowicz KE; Dong X; Liu L; Nim S; Dong A; Yang J; Li Y; Haddad D; Ernst A; Heerding D; Tong Y; Moffat J; Sidhu SS
J Mol Biol; 2017 Nov; 429(22):3546-3560. PubMed ID: 28587923
[TBL] [Abstract][Full Text] [Related]
7. USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth.
An T; Gong Y; Li X; Kong L; Ma P; Gong L; Zhu H; Yu C; Liu J; Zhou H; Mao B; Li Y
Biochem Pharmacol; 2017 May; 131():29-39. PubMed ID: 28216017
[TBL] [Abstract][Full Text] [Related]
8. USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.
Saha G; Sarkar S; Mohanta PS; Kumar K; Chakrabarti S; Basu M; Ghosh MK
Oncogene; 2022 Nov; 41(47):5061-5075. PubMed ID: 36243803
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a Potent and Selective Degrader for USP7.
Pei Y; Fu J; Shi Y; Zhang M; Luo G; Luo X; Song N; Mi T; Yang Y; Li J; Zhou Y; Zhou B
Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202204395. PubMed ID: 35691827
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway.
Dar A; Shibata E; Dutta A
Mol Cell Biol; 2013 Aug; 33(16):3309-20. PubMed ID: 23775119
[TBL] [Abstract][Full Text] [Related]
11. (1)H, (13)C and (15)N backbone resonance assignment for the 40.5 kDa catalytic domain of Ubiquitin Specific Protease 7 (USP7).
Di Lello P; Rougé L; Pan B; Maurer T
Biomol NMR Assign; 2016 Oct; 10(2):345-9. PubMed ID: 27386854
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule inhibitors of USP7 induce apoptosis through oxidative and endoplasmic reticulum stress in cancer cells.
Lee G; Oh TI; Um KB; Yoon H; Son J; Kim BM; Kim HI; Kim H; Kim YJ; Lee CS; Lim JH
Biochem Biophys Res Commun; 2016 Jan; 470(1):181-186. PubMed ID: 26768359
[TBL] [Abstract][Full Text] [Related]
13. Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism.
Schauer NJ; Liu X; Magin RS; Doherty LM; Chan WC; Ficarro SB; Hu W; Roberts RM; Iacob RE; Stolte B; Giacomelli AO; Perera S; McKay K; Boswell SA; Weisberg EL; Ray A; Chauhan D; Dhe-Paganon S; Anderson KC; Griffin JD; Li J; Hahn WC; Sorger PK; Engen JR; Stegmaier K; Marto JA; Buhrlage SJ
Sci Rep; 2020 Mar; 10(1):5324. PubMed ID: 32210275
[TBL] [Abstract][Full Text] [Related]
14. USP7 controls Chk1 protein stability by direct deubiquitination.
Alonso-de Vega I; Martín Y; Smits VA
Cell Cycle; 2014; 13(24):3921-6. PubMed ID: 25483066
[TBL] [Abstract][Full Text] [Related]
15. STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation.
Ye M; Tang Y; Tang S; Liu J; Wu K; Yao S; Sun Y; Zhou L; Deng T; Chen Y; Huang C; Tan W
Oncotarget; 2015 Oct; 6(33):34718-31. PubMed ID: 26460617
[TBL] [Abstract][Full Text] [Related]
16. Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.
Holowaty MN; Sheng Y; Nguyen T; Arrowsmith C; Frappier L
J Biol Chem; 2003 Nov; 278(48):47753-61. PubMed ID: 14506283
[TBL] [Abstract][Full Text] [Related]
17. Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
Qi SM; Cheng G; Cheng XD; Xu Z; Xu B; Zhang WD; Qin JJ
Front Cell Dev Biol; 2020; 8():233. PubMed ID: 32300595
[TBL] [Abstract][Full Text] [Related]
18. Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.
Reverdy C; Conrath S; Lopez R; Planquette C; Atmanene C; Collura V; Harpon J; Battaglia V; Vivat V; Sippl W; Colland F
Chem Biol; 2012 Apr; 19(4):467-77. PubMed ID: 22520753
[TBL] [Abstract][Full Text] [Related]
19. C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site.
Ma J; Martin JD; Xue Y; Lor LA; Kennedy-Wilson KM; Sinnamon RH; Ho TF; Zhang G; Schwartz B; Tummino PJ; Lai Z
Arch Biochem Biophys; 2010 Nov; 503(2):207-12. PubMed ID: 20816748
[TBL] [Abstract][Full Text] [Related]
20. USP7/HAUSP promotes the sequence-specific DNA binding activity of p53.
Sarkari F; Sheng Y; Frappier L
PLoS One; 2010 Sep; 5(9):e13040. PubMed ID: 20885946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
